What is ENFIERA 100 Injection?
ENFIERA 100 Injection is a prescription medicine containing Rituximab 100 mg/10 ml, a monoclonal antibody used to treat certain cancers and autoimmune diseases. It belongs to a class of medicines known as CD20-directed monoclonal antibodies. Rituximab works by specifically targeting a protein called CD20, which is found on the surface of certain B lymphocytes (B cells). These cells play an important role in some blood cancers and autoimmune disorders.
After binding to CD20, Rituximab helps the body’s immune system identify and destroy abnormal or overactive B cells. This targeted approach helps control disease progression while preserving many other healthy cells.
Doctors commonly prescribe ENFIERA 100 Injection for patients with specific blood cancers such as Non-Hodgkin lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL), as well as autoimmune disorders including Rheumatoid Arthritis (RA), Granulomatosis with Polyangiitis (GPA), and Microscopic Polyangiitis (MPA). Depending on the condition, it may be used alone or in combination with other medications such as chemotherapy.
Manufactured by Zydus Lifesciences Ltd., ENFIERA 100 Injection is administered as an intravenous infusion under close medical supervision in a hospital or infusion center.
Because Rituximab can cause serious infusion-related reactions and suppress parts of the immune system, ENFIERA 100 Injection should only be used under the supervision of a qualified healthcare professional.
Uses of ENFIERA 100 Injection
ENFIERA 100 Injection is prescribed for several medically approved conditions where B-cell depletion is beneficial.
It is commonly used for:
- Treatment of Non-Hodgkin Lymphoma (NHL)
- Treatment of Chronic Lymphocytic Leukemia (CLL)
- Management of Rheumatoid Arthritis (in combination with methotrexate)
- Treatment of Granulomatosis with Polyangiitis (Wegener’s Granulomatosis)
- Treatment of Microscopic Polyangiitis
- Certain cases of Pemphigus Vulgaris
- Supportive therapy for selected autoimmune disorders as recommended by specialists
This medicine should only be taken under the supervision of a qualified healthcare professional.
Benefits of ENFIERA 100 Injection
ENFIERA 100 Injection offers targeted treatment for conditions caused by abnormal or overactive B cells. By selectively reducing these cells, it can help improve disease control while minimizing damage to surrounding healthy tissues.
Potential benefits include:
- Helps control the growth of certain blood cancers
- Reduces disease activity in autoimmune disorders
- Improves symptoms such as joint pain and swelling in rheumatoid arthritis
- Supports long-term disease management
- May reduce flare-ups in approved autoimmune conditions
- Can improve quality of life when used as prescribed
- May enhance treatment outcomes when combined with chemotherapy in appropriate cancers
- Provides targeted immune therapy rather than broad immune suppression
Although ENFIERA 100 Injection is highly effective for many patients, it does not guarantee a cure, and treatment outcomes vary between individuals.
How Does ENFIERA 100 Injection Work?
The active ingredient, Rituximab, is a laboratory-produced monoclonal antibody designed to recognize the CD20 protein found on mature B lymphocytes.
Once attached to CD20, Rituximab helps eliminate these B cells through several natural immune mechanisms, including:
- Activation of the immune system
- Triggering programmed cell death (apoptosis)
- Recruiting immune cells to destroy abnormal B cells
Since abnormal B cells contribute to certain cancers and autoimmune diseases, removing them helps reduce disease activity, slow progression, and improve symptoms.
Because healthy B cells are also temporarily reduced, patients may become more susceptible to infections during treatment, making regular medical monitoring essential.
How to Take ENFIERA 100 Injection
ENFIERA 100 Injection is not self-administered.
General guidance includes:
- Administered by intravenous (IV) infusion after dilution.
- Given only by trained healthcare professionals.
- Treatment schedule depends on the medical condition being treated.
- Premedication may be given before infusion to reduce infusion-related reactions.
- Follow all appointments for treatment and monitoring.
- Do not skip or delay scheduled infusions without consulting your doctor.
- Never change your treatment schedule without medical advice.
Side Effects of ENFIERA 100 Injection
Like all medicines, ENFIERA 100 Injection may cause side effects, although not everyone experiences them.
Common Side Effects
- Fever
- Chills
- Fatigue
- Headache
- Nausea
- Skin rash
- Itching
- Low blood pressure during infusion
- Mild infections
- Cough
Serious Side Effects
Seek immediate medical attention if you experience:
- Severe allergic or infusion-related reactions
- Difficulty breathing
- Chest pain
- Severe infections
- Persistent fever
- Hepatitis B reactivation
- Progressive Multifocal Leukoencephalopathy (rare brain infection)
- Severe skin reactions
- Irregular heartbeat
- Tumor lysis syndrome (in some cancer patients)
If side effects persist or become severe, contact your healthcare provider promptly.
Warnings and Precautions
Before starting ENFIERA 100 Injection, inform your healthcare provider about your complete medical history.
Pregnancy
Use during pregnancy only if clearly needed. Rituximab may affect the developing baby’s immune system.
Breastfeeding
Breastfeeding should generally be avoided during treatment and for the period recommended by your physician after the final dose.
Liver Disease
Patients with hepatitis B require screening before treatment because Rituximab may reactivate the infection.
Kidney Disease
Use cautiously in patients with kidney impairment, particularly those receiving treatment for cancers with a high tumor burden.
Heart Disease
Patients with existing heart disease should be monitored carefully during infusion.
Elderly Patients
Older adults may have a higher risk of infections and may require closer monitoring.
Alcohol
No specific interaction is established, but discuss alcohol use with your healthcare provider.
Driving and Operating Machinery
If dizziness or fatigue occurs after infusion, avoid driving or operating heavy machinery.
Allergies
Do not use if you have had a severe allergic reaction to Rituximab or any component of the formulation.
Vaccinations
Live vaccines should generally be avoided during treatment because immune function may be reduced.
Drug Interactions
ENFIERA 100 Injection may interact with other medicines, potentially increasing the risk of infections or altering treatment effectiveness.
Inform your doctor if you take:
- Prescription medicines
- Over-the-counter medications
- Immunosuppressants
- Chemotherapy drugs
- Corticosteroids
- Herbal supplements
- Vitamins
- Vaccines, particularly live vaccines
Always provide a complete medication list before starting treatment.
Storage Instructions
Healthcare providers usually store and prepare ENFIERA 100 Injection.
General storage recommendations include:
- Store according to the manufacturer’s recommended temperature.
- Keep refrigerated if required by product labeling.
- Protect from direct sunlight.
- Do not freeze unless specified.
- Keep out of reach of children.
- Do not use after the expiry date.
- Single-use vial should be discarded after opening according to hospital protocols.
Disclaimer
The information provided above is intended for educational purposes only and should not be considered medical advice. ENFIERA 100 Injection should only be used under the guidance of a qualified healthcare professional. Do not self-medicate or alter your prescribed treatment without consulting your doctor. Individual responses to treatment may vary based on medical condition, overall health, and other medications.
Frequently Asked Questions (FAQs)
1. What is ENFIERA 100 Injection used for?
ENFIERA 100 Injection is used to treat certain blood cancers such as Non-Hodgkin lymphoma and Chronic Lymphocytic Leukemia, as well as autoimmune conditions including Rheumatoid Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis, and selected cases of Pemphigus Vulgaris.
2. How does ENFIERA 100 Injection work?
It contains Rituximab, which targets CD20-positive B cells. By reducing these cells, the medicine helps control abnormal immune activity and slow the progression of certain cancers and autoimmune diseases.
3. Is ENFIERA 100 Injection safe?
When administered under medical supervision and with appropriate monitoring, ENFIERA 100 Injection is considered safe for approved indications. However, it may cause serious side effects in some patients, requiring regular follow-up.
4. Can ENFIERA 100 Injection be used long term?
Some patients may receive long-term treatment depending on their condition. The duration of therapy is determined by the treating specialist based on disease response and overall health.
5. What happens if I miss an infusion?
If you miss a scheduled infusion, contact your healthcare provider as soon as possible. Do not attempt to adjust your treatment schedule on your own.
6. Can I stop treatment suddenly?
No. Treatment should not be discontinued without consulting your doctor, as this may affect disease control and future treatment planning.
7. Can ENFIERA 100 Injection be taken with food?
Since it is administered intravenously in a healthcare setting, food generally does not affect the medicine itself. Follow any dietary instructions provided by your healthcare provider before treatment.
8. What are the common side effects?
Common side effects include fever, chills, headache, fatigue, nausea, mild infections, rash, itching, and infusion-related reactions. Your healthcare team will monitor you during treatment.
9. Who should avoid ENFIERA 100 Injection?
Patients with a known allergy to Rituximab or those with certain severe active infections should not receive this medicine unless advised by a specialist after careful evaluation.
10. How should ENFIERA 100 Injection be stored?
The medicine should be stored according to the manufacturer’s recommendations, typically under refrigeration in healthcare facilities. It should be protected from light, kept out of reach of children, and never used beyond its expiry date.
Reviews
There are no reviews yet.